PrEPVacc: HIV vaccine trial that could be 'the last roll of the dice' this decade is underway

Coordinated out of Uganda, the first-of-its-kind study is taking a double-pronged attack to HIV. Failure could mean no vaccine until at least the 2030s.

Related Keywords

Durban ,Kwazulu Natal ,South Africa ,Luganda ,Ouest ,Rwanda ,Entebbe ,Wakiso ,Uganda ,Verulam ,Thailand ,Dar Es Salaam ,Tanzania ,Mbeya ,Dar Es Salam ,Masaka ,Melbourne ,Victoria ,Australia ,London ,City Of ,United Kingdom ,Ugandan ,Sharon Lewin ,Europe Getty ,Eugene Ruzagira ,Luwano Geofrey ,Nishanta Singh ,Helena Herholdt ,Jonathan Weber ,Cnn ,Uganda Virus Research Institute ,Muhimbili University Of Health ,Imperial College Academic Health Science Centre ,Data Monitoring Committee ,University Of Melbourne ,Medical Research ,European Union Sponsored ,Disease Control ,Trial Director ,Getty Images ,Independent Data Monitoring ,Muhimbili University ,Allied Sciences , ,